18 September 2018 - Deborah Wilkes
Europe's Committee for Medicinal Products for Human Use (CHMP) has elected Germany's Harald Enzmann as chair for a three-year term.
Enzmann is head of European and international affairs at Germany's Federal Institute for Drugs and Medical Devices (BfArM). He has been a member of the CHMP since 2005 and its vice-chair since October 2016.
He replaces Tomas Salmonson – senior scientific adviser at the Swedish Medical Products Agency (MPA) – who has served the maximum of two three-year terms as chair of the CHMP.
Commenting on his new role, Enzmann said the CHMP was at the "cutting edge of medical progress". "With science evolving at such a fast pace, our challenge will be to achieve a balance between being agile to find solutions to emerging scientific or regulatory issues and being consistent with previous decisions,” he added.
“As chair," continued Enzmann, "I will try to elicit in a constructive way the committee members’ views, encourage their involvement and structure our scientific discussions to foster consensual decision-making.”
Take out an Annual Subscription to the OTCToolbox website, giving you UNLIMITED ACCESS to all of our publications
* Premium News Stories
* OTCToolbox Innovations magazine NEW IDEAS BETTER WAYS
* OTCToolbox Deals Database
* News Extras
* OTC Deal Trends Briefing
* OTC Company Strategies Report
Helping you and your company make well-informed decisions
CLICK HERE TO FIND OUT MORE